Clinical Trial Update: Astra Zeneca (Immuno Stereotactic Ablative Body Radiotherapy) ISABR Study: Randomized Phase I/II Study of Stereotactic Body Radiotherapy [Phase 1, Phase 2]

View source ↗

Summary

The ISABR trial is a randomized Phase I/II study evaluating immuno stereotactic ablative body radiotherapy for non-small cell lung cancer. The trial is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING